BiotechTube
Home/Keapstone Therapeutics/Arthur Roach
AR

Arthur Roach

Board Member, Director of Research at Parkinson's UK

Keapstone Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesParkinson's DiseaseAmyotrophic Lateral Sclerosis (ALS)

Keapstone Therapeutics Pipeline

DrugIndicationPhase
Nrf2 Activator ProgramParkinson's DiseasePre-clinical

Leadership Team at Keapstone Therapeutics

DR
Dr Richard Mead
Co-Founder, Board Member, Senior Lecturer at SITraN
DP
Dame Professor Pamela Shaw
Co-Founder, Director of SITraN
RM
Ross McMaster
Company Secretary, Board Member, Financial Consultant
View full Keapstone Therapeutics profile